Literature DB >> 16504865

Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.

Yee-Min Jen1, Yu-Ching Lin, Yi-Bing Wang, Der-Min Wu.   

Abstract

OBJECTIVES: This study evaluates: (1) the change in whole salivary secretion rates of nasopharyngeal carcinoma patients before, during, and after radiotherapy, especially during the first week of irradiation; (2) the recovery capability of salivary glands up to 2 years postirradiation; and (3) the possible prognostic factors affecting salivary gland functions. STUDY
DESIGN: Fifty patients who completed conventional radiotherapy using either once-per-day or hyperfractionated technique were included. Both unstimulated and stimulated whole salivary flow rates and ratios (flow rate compared with baseline) were measured before, during, 1, 3, and 6 months, and 1 and 2 years after radiotherapy. Multivariate analysis of potential prognostic factors affecting the salivary secretion ratio was made.
RESULTS: Salivary glands were very radiosensitive and responded to radiation very early. After 720 cGy at the fourth day of the 8-week treatment, the unstimulated and stimulated salivary flow rates had decreased by 40%-50%. The nadir was reached in many patients after 3600 cGy (4 weeks). A second phase of decrease in salivary secretion was noted after completion of radiotherapy.
CONCLUSIONS: Different mechanisms may be responsible for salivary response after low and high dose of radiation. This study shows no recovery of salivary secretion during the follow-up period, and the best strategy for managing radiation-induced salivary gland damage may be reduction of radiation dose to the glands.

Entities:  

Mesh:

Year:  2005        PMID: 16504865     DOI: 10.1016/j.tripleo.2005.01.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  9 in total

1.  Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI.

Authors:  Chun-Jung Juan; Cheng-Yu Chen; Yee-Min Jen; Hua-Shan Liu; Yi-Jui Liu; Chun-Jen Hsueh; Chao-Ying Wang; Yu-Ching Chou; Yao-Te Chai; Guo-Shu Huang; Hsiao-Wen Chung
Journal:  Eur Radiol       Date:  2008-07-26       Impact factor: 5.315

2.  Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.

Authors:  Christina P C Sim; Joseph Wee; Ying Xu; Yin-Bun Cheung; Yoke-Lim Soong; David J Manton
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

Review 3.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

4.  The Effect of a Combination Saliva Substitute for the Management of Xerostomia and Hyposalivation.

Authors:  R C Lapiedra; G E Gómez; B P Sánchez; A A Pereda; M D Turner
Journal:  J Maxillofac Oral Surg       Date:  2015-03-14

5.  Evaluation of Radiation-induced Xerostomia in Patients with Nasopharyngeal Carcinomas.

Authors:  Narmin Mohammadi; Farshad Seyyednejhad; Parnian Alizadeh Oskoee; Siavash Savadi Oskoee; Niloofar Mofidi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2007-09-10

6.  Step-by-step full mouth rehabilitation of a nasopharyngeal carcinoma patient with tooth and implant-supported prostheses: A clinical report.

Authors:  Marzieh Alikhasi; Mahmood Kazemi; Saeed Nokar; Arash Khojasteh; Sedigheh Sheikhzadeh
Journal:  Contemp Clin Dent       Date:  2011-07

7.  Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II).

Authors:  Charlotte Duch Lynggaard; Christian Grønhøj; Robin Christensen; Anne Fischer-Nielsen; Jacob Melchiors; Lena Specht; Elo Andersen; Jann Mortensen; Peter Oturai; Gry Hoffmann Barfod; Eva Kannik Haastrup; Michael Møller-Hansen; Mandana Haack-Sørensen; Annette Ekblond; Jens Kastrup; Siri Beier Jensen; Christian von Buchwald
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

8.  Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.

Authors:  Hiroyuki Harada; Ken Omura; Hirofumi Tomioka; Hideki Nakayama; Akimitsu Hiraki; Masanori Shinohara; Yasuto Yoshihama; Satoru Shintani
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

9.  Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.

Authors:  Chun-Jung Juan; Cheng-Chieh Cheng; Su-Chin Chiu; Yee-Min Jen; Yi-Jui Liu; Hui-Chu Chiu; Hung-Wen Kao; Chih-Wei Wang; Hsiao-Wen Chung; Guo-Shu Huang; Hsian-He Hsu
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.